References
Original article
Lenz, H. J. et al. First-line nivolumab plus low-dose ipilimumab for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. J. Clin. Oncol. https://doi.org/10.1200/JCO.21.01015 (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. MSI-H/dMMR mCRC: ICIs in the first line?. Nat Rev Clin Oncol 18, 748 (2021). https://doi.org/10.1038/s41571-021-00576-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-021-00576-z
- Springer Nature Limited